Why NovoCure Stock Was Withering on Wednesday
Cancer-focused biotech NovoCure (NVCR -4.07%) saw its stock price target cut by Wedbush analyst David Nierengarten from $29 to $27, ...
Thursday, June 19, 2025
Tag: Withering
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.